DAFTAR PUSTAKA
1.
Wiersinga W, Bonten M, Boersma W, Jonkers R, Aleva R, Kullberg B, et al. Management of Community Acquired Pneumonia in Adults. Guideline update. SWAB. 2016. P:1-93.2.
Watkins R, Lemonovich T. Diagnosis and management of Community Acquired Pneumonia in adults. AAFP. 2011. P:1299-1306.3.
Gibson G, Loddenkemper R, Lundback B, Sibille Y. Respiratory health and disease in Europe: The new European Lung White Book. Eur Respir J. 2013. P: 559-63.4.
Rozenbaum M, Mangen M, Huijts S, van der Werf T, Postma M. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis. Vaccine. 2015. P: 3193-9.5.
Pahriyani A, khotimah N, bakar L. 2015. Evaluasi penggunaan antibiotik pada pasien community acquired pneumonia (CAP) di RSUD budi asih Jakarta timur. Jakarta: Farmasains vol. 2 no 6. 2015.6.
Laporan Rekam Medis. Padang: RSUP.Dr. M. Djamil. 2016.7.
Florian B, Sachin Y, Derek C. Epidemiology of severe sepsis. 2014. P: 4–11.8.
Sousa C, Brandao M, Ribeiro, O, Cardoso, T. Community-Acquired Severe Sepsis: A Prospective Cohort Study. Open Journal of Internal Medicine. 2015. P: 37-49.9.
Treziak S, Dellinger R, Parillo J. Septic shock in Critical Care Medicine Principles of Diagnosis and Management in the Adult, fourth edition. Philadelphia: Elsevier. 2014. P: 632-64110.
Munford R. Severe sepsis and septic shock in Harrison’s Principles of Internal Medicine,
eighteenth edition. New York: McGraw-Hill. 2012. P: 214-22811.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M, Bellomo R, et al.
The third international consensus definitions for sepsis and septic shock. JAMA. 2016. P: 801-810.12.
Tupchong K, Koyfman A, Foran M. Sepsis, severe sepsis, and septic shock: A review of the
literature. African Journal of Emergency Medicine. 2015. P: 127-135.13.
Phue. Management of severe sepsis in patients admitted to Asian intensive care units:
prospective cohort study. BMJ. 2011. P:1-1114.
Pradipta. Antibiotik use evaluation at ward of internal medicine dr. Sardjito hospital
November-December 2008 (thesis). Faculty of Pharmacy. Indonesia: Universitas Gadjah Mada. 2009. P: 48-55.15.
Rekam Medis RSUP M. Djamil Padang. 2014.
16.
Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer R, Kumar A, et al. Surviving
sepsis campaign: International guidelines for management of sepsis and septic shock. CCM Journal. 2017. P: 45-8.17.
Asakura H. Classifying types of disseminated intravascular coagulation. Journal of Intensive
Care. 2014. P: 1-7.18.
Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant
therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2015. P: 518-530.19.
Okamoto K, Tamura T, Sawatsubashi Y. Sepsis and disseminated intravascular coagulation.
Journal of Intensive Care. 2016. P: 4-23.20.
Sungko B, Young C, Mok R, Chun K, Woong J, Hyuk P. The Prevalence and Significance of
Overt Disseminated Intravascular Coagulation in Patients with Septic Shock in the EmergencyDepartment According to the Third International Consensus Definition. Korean J Crit Care Med. 2016. P: 334-341.
21.
Rodgers, Goerge M. Acquired Coagulation Disorders. In Wintrobe's Clinical Hematology 13th
Ed. Editor: Greer et al. Lippincott Williams & Wilkins. Philadelphia. 2014. P: 1186 - 1215.22.
Rahajuningsih. Patofisiologis DIC dan Fibrinolisis. Dalam Hemostasis dan Trombosis. Editor:
Setiabudy R. Indonesia: Fakultas Kedokteran Universitas Indonesia. 2014. P: 108 -19.
23.
Amit N, Ravindra, Parineeta S, Anjali K. International society on thrombosis and haemostasis
disseminated intravascular coagulation scoring system: is it a good prognostic indicator in dic. Int J Med Res Health Sci. 2015. P: 546-550.24.
Semeraro N, Ammollo C, Semeraro F, Colucci M. Coagulopathy of acute sepsis. Semin
Thromb Hemost. 2015. P:650-658.25.
Suharti C. Koagulasi intavaskular diseminata. Dalam: buku ajar Ilmu Penyakit Dalam Pusat
Penerbit Departemen Ilmu Penyakit Dalam. Jakarta: Fakultas Kedokteran Universitas Indonesia jilid II edisi VI. 2014. P: 2789-2795.26.
Hussain I, Saba, Genevieve A. The Pathogenesis and Management of Disseminated
Intravascular Coagulation. In: Clinical Advances in Hematology & Oncology. 2008. P: 919 - 26.27.
Setiabudy RD. Patofisiologi trombosis. Dalam: Hemostasis dan trombosis, ed.4. Setiabudy
RD,ed. Jakarta: Balai Penerbit FKUI. 2014. P: 34-47.28.
Levi M, Poll T. Coagulation in patients with severe sepsis. Semin Thromb Hemost. 2015. P:
9-15.29.
Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated Intravascular
coagulation (DIC) according to four DIC guidelines. Journal of Intensive Care. 2014. P : 1-8.30.
Adcock D, Bethel M, Macy P. Coagulation handbook.
2006. P:147-158.31.
Satoshi, Nanzaki S, Sasaki, Shigeyuki. Activation of the extrinsic coagulation pathway in
patients with severe sepsis and septic shock. Critical Care Medicine. 1998. P: 2005-8.32.
Gando S, Nanzaki S, Sasaki S. Significant Correlations between Tissue Factor and Trombin
Markers in Trauma and Septic Patients with Disseminated Intravascular Coagulation. Thrombosis and Haemostasis. 1998. P: 1068-1220.33.
Kinasewitz G, Yan B, Basson B, Comp P. Universal changes in biomarkers of coagulation and
inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Critical Care. 2004. P: 82-4.34.
Koyama K, Madoiwa S, Nunomiya S. Combination of trombin-antitrombin complex,
plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study. Critical Care. 2014. P: 13-5.35.
Kretz C, Vaezzadeh N, Gross P. Tissue factor and thrombosis models. Journal of the American
Heart Association. 2010. P: 900-8.36.
Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue
factor is related from endothelial cells in response to inflammatory cytokines. Circulation Research, Journal of the American Heart Association. 2004. P: 1233-9.37.
Gonzalez J, Anand S, Zafar M, Fuster V, Badimon J. Tissue factor Coagulation Pathway: A
New Therapeutic Target. Journal of Pharmacology. 2004. P: 669-76.38.
Milbrandt E, Reade M, Lee M, Stephanie L, Angus D, Kong L, et al. Prevalence and
Significance of Coagulation Abnormalities in Community-Acquired Pneumonia. Molmed 15. 2009. P: 438-45.39.
Brown J, Calverley P, Dusmet M, Elborn J, Fisher A, Fitzgerald J, et al. BTS guidelines for the
management of community acquired pneumonia in adult. BTS. 2009. P: 1-55.40.
Indonesia PDPI. Pneumonia Komuniti: Pedoman Diagnosis dan Penatalaksanaan di Indonesia.
Jakarta: Balai Penerbit FKUI. 2003. P:1-1241.
Niederman M, Mandell L, Anzueto A, Bass J, Brouhton W, Campbell G
et al. American Thoracic Society. Guidelines for the management of adults with community acquired of adults with community acquire pneumonia. Diagnosis, assestment of severity, antimicrobial theraphy, and prevention. Am J Resp Crit Care Med. 2001. P: 1730-54.42.
Parrillo J, Nduka O. The pathophysiology of septic shock. Annals of Intensive Care. 2011. P:
677-702.43.
Vincent J. The Clinical Challenge of Sepsis Identification and Monitoring. PLoS Med 13(5).
2016. P:132-13844.
Guntur A. Sepsis. Buku ajar ilmu penyakit dalam. Jakarta : Interna publishing: 2014. P:1-17
45.
Levi M, Toh C, Tachil J, Whatson G. Guidelines for the diagnosis and management of
disseminated intravascular coagulation. British Journal of Haematology. 2011. P: 24-33.
46.
Wada H, Tachil J, Nisio M, Mathew P, Kurosawa S, Gando,
et al. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. International Society on Thrombosis and Haemostasis. 2014. P: 761-7.47.
Hock Toh C, Alhamdi Y. Current consideration and management of disseminated intravascular
coagulation. American Society of Hematology. 2013. P: 286-91.48.
Asakura H, Takahashi H, Uchiyama T. Proposal for new diagnostic criteria for DIC from the
Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016. P: 14:42.49.
Gao F, Linhartova, Johnston, Thickett R. Statins and sepsis. British Journal of Anaesthesia.
2008. P: 288–98.50.
Amit N, Ravindra, Parineeta S, Anjali K. International society on thrombosis and haemostasis
disseminated intravascular coagulation scoring system: is it a good prognostic indicator in dic. Int J Med Res Health Sci. 2015. P: 546-50.51.
Song W, Choi R. Plasma Factor XIII Activity in Patients with Disseminated Intravascular
Coagulation. Yonsei Medical Journal. 2008. P:196 – 200.52.
Iba T, DiNisio, M, Thachil J. Revision of the Japanese Association for Acute Medicine
(JAAM)-disseminated intravascular coagulation (DIC) diagnostic criteria using antitrombin activity. Crit Care Journal. 2016. P: 20-287.53.
Patnaik M, Moll S. Inherited antitrombin deficiency: a review. Haemophilia. 2008. P:1229-39.
54.
Simmons J, Pittet J. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol. 2015.
P:227-236.
55.
Chu, Arhur J. Tissue factor, Blood coagulation, and Beyond: an overview. International Journal
of Inflammation. 2011. P: 1-28.56.
Owens, Mackman N.
Tissue factor and thrombosis : The clot starts here. NIH Access in ThromHaemost. 2010. P: 432-9.57.
Firmansyah A, Amin Z, Loho T and Shatri H. Faktor-Faktor Prediktor Mortalitas
Community-Acquired Pneumonia dalam Perawatan Inap di Rumah Sakit Cipto Mangunkusumo. Jakarta:
CHEST Critical and Emergency Medicine Vol. 2, No. 2 Apr - Jun 2015.
58.
Pitaloka S, wibisono B. Beberapa faktor risiko yang berhubungan dengan kematian pasien
pneumonia komunitas di RSUP dr. Kariadi semarang. Semarang: media medika muda volume 4, nomor 4. Oktober 2015.59.
Egorina E, Sovershaev M, Hansen J. The role of tissue factor in systemic inflammatory
response syndrome. Blood Coagul Fibrinolysis. 2011. P: 451-6.60.
Wunderink G, Laterre P, Francois B, Perrotin D, Artigas A, Vidal L, et al. Recombinant Tissue
Factor Pathway Inhibitor in Severe Community-acquired Pneumonia. Am J Respir Crit Care Med Vol 183. 2011. P: 1561-8.61.
Xue M, Sun Z, Shao M, Yin J, Deng Z, Zhang J. Diagnostic and prognostic utility of tissue
factor for severe sepsis and sepsis-induced acute lung injury. Journal of Translational Medicine. 2015. P: 13-172.62.
Rijneveld A, Weije S, Bresser P, Florquin S, Vlasuk G, Rote W. Local activation of the tissue
factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med 2006 Vol. 34 No. 6.63.
Plat A. Can you recognize a patient at risk for a hypercoagulable state?. JAAPA 2008. P: 20-6.
64.
Semeraro N, Concetta T, Fabrizio S, Mario C. Sepsis-Associated Dissemin Thromboembolic
Disease. Italy: Department of Biomedical Sciences and Human Oncology, Section of General and Experimental Pathology, University of Bari. 2010. P:1-3.
